3Plebanski M,Lee EA,Hannan CM,et al.Altered peptide ligends narrow the repertoire of cellular immune responses by interfering with T-cell priming.Nat Med,1999,5:565-571.
4Kuchroo VK,Greer JM,Kaul D,et al.A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire.J Immunol,1994,153:3326-3336.
5Brocke S,Gijbels K,Allegretta M,et al.Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein.Nature,1996,379:343-346.
6Kita H,Matsumura S,He XS,et al.Analysis of TCR antagonism and molecular mimicry of an HLA-A * 0201-restricted CTL epitope in primary biliary cirrhosis.Hepatol,2002,36:918-926.
7Bertoletti A,Sette A,Chisari FV,et al.Natural analogues of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells.Nature,1994,369:407-410.
8Prince M,AmandaC,NewmanW,etal.Survivaland symptom progression in a geographically based cohort of patients with primary biliary cirrhosis:follow-up for up to 28 years.Gastroenterol,2002,123:1044-1051.
10Suzuki A,Van de Water J,Gershwin ME,et al.Oral tolerance and pyruvate dehydrogenase in patients with primary biliary cirrhosis.Dev Immunol,2002,9(2):55-61.
8Manns MP,Czaja AJ,Gorham JD,et al.Diagnosis and management of autoimmune hepatitis[J].Hepatology,2010,51(6):2193-2213.
9Heathcote EJ.Management of primary biliary cirrhosis.The American Association for the Study of Liver Diseases practice guidelines[J].Hepatology,2000,31(4):1005-1013.
10Czaja AJ.Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis:a foray across diagnostic boundaries[J].J Hepatol,2006,44(2):251-252.
